Action Needed from the FDA: Approval to Treat Adolescent Depression with Transcranial Magnetic Stimulation (TMS)

Advocacy
Written By Len Lantz, MD

Image: Family by Anastasia Gepp (CC0)

 

Synopsis: Transcranial Magnetic Stimulation (TMS) therapy, one of the most effective treatments for major depression, has been FDA approved for adults for 14 years. The FDA has not yet approved TMS for adolescent depression even though they approved a TMS device for migraine headaches in children. This article reviews research that shows TMS for adolescent depression to be safe, feasible, and effective.

BY LEN LANTZ, MD / 1.26.22; No. 55 / 9 min read

This article has been archived as it no longer has current information due to the FDA’s 3/22/24 approval of TMS therapy for adolescent depression. For a more recent article on TMS for adolescent depression, please see my article titled, “A New Treatment for Adolescent Depression: FDA Approves Transcranial Magnetic Stimulation (TMS).”

 
Len Lantz, MD
Previous

Change Depressive Habits when the Wind Is at Your Back
Next

Universal Screening for Depression and Sustained Sadness in Kids to Prevent Youth Suicide